drugset / Trial / NCT06710899

Vitamin C and Hiprex in rUTI

NCT06710899

Phase 0 Not yet recruiting 20 enrolled University Hospitals of North Midlands NHS Trust
Non-randomizedSequentialOpen-labelTreatment

Summary

A single centre proof of concept study to assess whether Vitamin C improves the efficacy of Methenamine Hippurate (Hiprex®) in the prophylaxis of recurrent urinary tract infections (rUTIs) in women

Timeline

Start
2027-01
Primary completion
2027-08
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methenamine Hippurate Unknown 1 g
Subject Vitamin C Other / unclassified 1 g